Inventaire - your friends and communities are your best library

Antibody polyspecificity and neutralization of HIV-1: a hypothesis

author

Garnett Kelsoe

Barton Haynes

Munir Alam

M Anthony Moody

Laurent Verkoczy

published in: Human Antibodies

date of publication: 2005-01-01

main subject: HIV, antibody

Cites articles 69

Date

Title

Authors

2005-01-01

What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
2005-01-01

Immunoglobulin gene diversification
2005-09-07

Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

Ian Andrew Wilson, Chi-Huey Wong, Dennis R. Burton, Robyn L Stanfield, Daniel A Calarese, Hing-Ken Lee
2005-06-01

Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow

Garnett Kelsoe
2005-04-28

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies

Renate Kunert, Herman Staats, Barton Haynes, E. William St. Clair, Hua-Xin Liao
2005-02

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

Ian Andrew Wilson, Dennis R. Burton
2005-01-01

Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences
2005-02-08

Identification and characterization of circulating human transitional B cells
2005-01-01

Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1

Renate Kunert, Dennis R. Burton
2005-06-01

B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88

Satoshi Uematsu, Richard B S Roden
2004-12-01

The scope of receptor editing and its association with autoimmunity
2004-10-01

CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
2004-10-01

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

John R. Mascola, Peter D. Kwong, Richard T. Wyatt, Gilad Ofek
2004-08-24

Autoantibodies, lupus and the science of sabotage
2004-04-01

Regulation of B-cell development by antibody specificity
2004-01-01

Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression

Garnett Kelsoe
2004-06-10

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

Birte Steiniger, Jean-Laurent Casanova, Sandra Weller, Corinne Cordier, Andreas Rosenwald, Claude-Agnès Reynaud
2004-07-01

Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes

Carl S Goodyear
2004-04-01

Human immunodeficiency virus infection and systemic lupus erythematosus
2004-03-01

HIV vaccine design and the neutralizing antibody problem.

Ian Andrew Wilson, Joseph Sodroski, Gary Nabel, Peter D. Kwong, Dennis R. Burton, Richard T. Wyatt
2004-02-01

T cell-independent somatic hypermutation in murine B cells with an immature phenotype
2003-12-05

Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide

Christine Katlama, Bonaventura Clotet Sala, Antonella Castagna, Sharon Walmsley
2003-12-15

Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen
2003-09-01

Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals,Binding and Neutralization Activity of Human IgG1 and IgG3 from Serum of HIV-Infected Individuals
2003-04-01

Hypermutation in human B cells in vivo and in vitro

Sandra Weller, Said Aoufouchi, Claude-Agnès Reynaud
2003-03-01

Antibody neutralization and escape by HIV-1

Jesus F Salazar-Gonzalez, J. Michael Kilby, Beatrice H. Hahn, George M. Shaw, Martin A. Nowak, Peter D. Kwong, Michael Saag, Huxiong Hui, John C Kappes
2003-04-01

Rapid evolution of the neutralizing antibody response to HIV type 1 infection
2003-11-01

A fail-safe mechanism for negative selection of isotype-switched B cell precursors is regulated by the Fas/FasL pathway,A Fail-safe Mechanism for Negative Selection of Isotype-switched B Cell Precursors Is Regulated by the Fas/FasL Pathway
2003-05-01

Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy

Antonietta D'antuono
2002-12-12

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

Joseph Sodroski, Richard T. Wyatt, Peter D. Kwong
2002-09-01

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome
2002-07-01

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Erica Ollmann Saphire, Ian Andrew Wilson, Dennis R. Burton

Article - wd:Q36487151

Welcome to Inventaire

the library of your friends and communities

learn more